Artwork

Content provided by Rosalina and Shauna. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rosalina and Shauna or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

S2E9: Hormone Therapy | Aromatase Inhibitors | Ovarian Suppression

46:44
 
Distribuie
 

Manage episode 353131439 series 3439740
Content provided by Rosalina and Shauna. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rosalina and Shauna or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

The anticipation is here. We discuss the dreading topic of endocrine therapy to help slow and stop cancer cell growth for the next 5-10 years. From early menopause w/ovarian suppression (which can be reversible) to the not-so-great side effects, we talk about it all in this episode. Rosalina and Shauna have two completely different plans, which makes it interesting to learn more about their approach post-cancer treatment.

Resources:

HormoneTherapy: https://www.breastcancer.org/treatment/hormonal-therapy

CDK 4/6 inhibitor (Verzenio - FDA approved to be used for early-stage breast cancer) - https://www.breastcancer.org/research-news/verzenio-approved-to-treat-early-hr-pos-bc-with-high-risk-of-recurrence

Zometa infusion (to strengthen bones): https://www.cancernetwork.com/view/early-efficacy-observed-with-trastuzumab-deruxtecan-pertuzumab-for-her2-metastatic-breast-cancer

If you enjoy this episode, please share it with your friends. Help us reach more women by subscribing and rating us on Apple Podcast, Spotify, and YouTube.

You can follow us on Instagram @TYFTSpodcast and email us at tyftspodcast@gmail.com

Visit our website, and check out our resources: https://tyftspodcast.com/

  continue reading

59 episoade

Artwork
iconDistribuie
 
Manage episode 353131439 series 3439740
Content provided by Rosalina and Shauna. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rosalina and Shauna or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

The anticipation is here. We discuss the dreading topic of endocrine therapy to help slow and stop cancer cell growth for the next 5-10 years. From early menopause w/ovarian suppression (which can be reversible) to the not-so-great side effects, we talk about it all in this episode. Rosalina and Shauna have two completely different plans, which makes it interesting to learn more about their approach post-cancer treatment.

Resources:

HormoneTherapy: https://www.breastcancer.org/treatment/hormonal-therapy

CDK 4/6 inhibitor (Verzenio - FDA approved to be used for early-stage breast cancer) - https://www.breastcancer.org/research-news/verzenio-approved-to-treat-early-hr-pos-bc-with-high-risk-of-recurrence

Zometa infusion (to strengthen bones): https://www.cancernetwork.com/view/early-efficacy-observed-with-trastuzumab-deruxtecan-pertuzumab-for-her2-metastatic-breast-cancer

If you enjoy this episode, please share it with your friends. Help us reach more women by subscribing and rating us on Apple Podcast, Spotify, and YouTube.

You can follow us on Instagram @TYFTSpodcast and email us at tyftspodcast@gmail.com

Visit our website, and check out our resources: https://tyftspodcast.com/

  continue reading

59 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință